Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase

Neuron

Volumn 82, Issue 1, 2014, Pages 195-207

  Zhang, Jingfei ^a   Malik, Aqsa ^a   Choi, Hyun B ^a   Ko, Rebecca W Y ^a   Dissing Olesen, Lasse ^a   MacVicar, Brian A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 3; GLUTAMATE RECEPTOR; LIPOPOLYSACCHARIDE; PHOSPHOPROTEIN PHOSPHATASE 2A; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; HIPPOCAMPUS; HYPOXIA; INTERNALIZATION; LONG TERM DEPRESSION; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; SYNAPTIC TRANSMISSION;

ACETOPHENONES; ANIMALS; ANIMALS, NEWBORN; ANOXIA; ANTIGENS, CD11B; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; LONG-TERM SYNAPTIC DEPRESSION; MACROPHAGE-1 ANTIGEN; MICE; MICE, KNOCKOUT; MICROGLIA; NADPH OXIDASE; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84897401619     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2014.01.043     Document Type: Article

References (54)

1. Ahmadian G., Ju W., Liu L., Wyszynski M., Lee S.H., Dunah A.W., Taghibiglou C., Wang Y., Lu J., Wong T.P., et al. Tyrosine phosphorylation of GluR2 is required for insulin-stimulated AMPA receptor endocytosis and LTD. EMBO J. 2004, 23:1040-1050.
2. Barnham K.J., Masters C.L., Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 2004, 3:205-214.
3. Beattie E.C., Carroll R.C., Yu X., Morishita W., Yasuda H., von Zastrow M., Malenka R.C. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat. Neurosci. 2000, 3:1291-1300.
4. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
5. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
6. Caraballo J.C., Yshii C., Butti M.L., Westphal W., Borcherding J.A., Allamargot C., Comellas A.P. Hypoxia increases transepithelial electrical conductance and reduces occludin at the plasma membrane in alveolar epithelial cells via PKC-ζ and PP2A pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 300:L569-L578.
7. Collingridge G.L., Peineau S., Howland J.G., Wang Y.T. Long-term depression in the CNS. Nat. Rev. Neurosci. 2010, 11:459-473.
8. Drummond G.R., Selemidis S., Griendling K.K., Sobey C.G. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 2011, 10:453-471.
9. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 2001, 24:31-55.
10. Fekete A., Vizi E.S., Kovács K.J., Lendvai B., Zelles T. Layer-specific differences in reactive oxygen species levels after oxygen-glucose deprivation in acute hippocampal slices. Free Radic. Biol. Med. 2008, 44:1010-1022.
11. Flaherty S.F., Golenbock D.T., Milham F.H., Ingalls R.R. CD11/CD18 leukocyte integrins: new signaling receptors for bacterial endotoxin. J. Surg. Res. 1997, 73:85-89.
12. Gao H.M., Zhou H., Zhang F., Wilson B.C., Kam W., Hong J.S. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J. Neurosci. 2011, 31:1081-1092.
13. Gao H.M., Zhou H., Hong J.S. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Pharmacol. Sci. 2012, 33:295-303.
14. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 2004, 142:231-255.
15. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
16. Hauss-Wegrzyniak B., Lynch M.A., Vraniak P.D., Wenk G.L. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp. Neurol. 2002, 176:336-341.
17. Hickman S.E., Kingery N.D., Ohsumi T.K., Borowsky M.L., Wang L.C., Means T.K., El Khoury J. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 2013, 16:1896-1905.
18. Hines D.J., Choi H.B., Hines R.M., Phillips A.G., MacVicar B.A. Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides. PLoS ONE 2013, 8:e60388.
19. Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J., et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 2013, 368:107-116.
20. Kasai H., Fukuda M., Watanabe S., Hayashi-Takagi A., Noguchi J. Structural dynamics of dendritic spines in memory and cognition. Trends Neurosci. 2010, 33:121-129.
21. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011, 91:461-553.
22. Kettenmann H., Kirchhoff F., Verkhratsky A. Microglia: new roles for the synaptic stripper. Neuron 2013, 77:10-18.
23. Knapp L.T., Klann E. Potentiation of hippocampal synaptic transmission by superoxide requires the oxidative activation of protein kinase C. J. Neurosci. 2002, 22:674-683.
24. Loiarro M., Sette C., Gallo G., Ciacci A., Fantò N., Mastroianni D., Carminati P., Ruggiero V. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-kappaB. J. Biol. Chem. 2005, 280:15809-15814.
25. Maalouf M., Rho J.M. Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies. J. Neurosci. Res. 2008, 86:3322-3330.
26. Mann D.A., Frankel A.D. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 1991, 10:1733-1739.
27. Mulkey R.M., Herron C.E., Malenka R.C. An essential role for protein phosphatases in hippocampal long-term depression. Science 1993, 261:1051-1055.
28. Nicholls R.E., Alarcon J.M., Malleret G., Carroll R.C., Grody M., Vronskaya S., Kandel E.R. Transgenic mice lacking NMDAR-dependent LTD exhibit deficits in behavioral flexibility. Neuron 2008, 58:104-117.
29. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
30. Nizet V., Johnson R.S. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 2009, 9:609-617.
31. Nolan Y., Martin D., Campbell V.A., Lynch M.A. Evidence of a protective effect of phosphatidylserine-containing liposomes on lipopolysaccharide-induced impairment of long-term potentiation in the rat hippocampus. J. Neuroimmunol. 2004, 151:12-23.
32. Peers C., Dallas M.L., Boycott H.E., Scragg J.L., Pearson H.A., Boyle J.P. Hypoxia and neurodegeneration. Ann. N Y Acad. Sci. 2009, 1177:169-177.
33. Pei Z., Pang H., Qian L., Yang S., Wang T., Zhang W., Wu X., Dallas S., Wilson B., Reece J.M., et al. MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity. Glia 2007, 55:1362-1373.
34. Pi H.J., Lisman J.E. Coupled phosphatase and kinase switches produce the tristability required for long-term potentiation and long-term depression. J. Neurosci. 2008, 28:13132-13138.
35. Qin L., Liu Y., Wang T., Wei S.J., Block M.L., Wilson B., Liu B., Hong J.S. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 2004, 279:1415-1421.
36. Raddatz E., Thomas A.C., Sarre A., Benathan M. Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H820-H835.
37. Relman D., Tuomanen E., Falkow S., Golenbock D.T., Saukkonen K., Wright S.D. Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell 1990, 61:1375-1382.
38. Rey F.E., Cifuentes M.E., Kiarash A., Quinn M.T., Pagano P.J. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ. Res. 2001, 89:408-414.
39. Reynolds A., Laurie C., Mosley R.L., Gendelman H.E. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int. Rev. Neurobiol. 2007, 82:297-325.
40. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet V., Johnson R.S., Haddad G.G., Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453:807-811.
41. Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., Ransohoff R.M., Greenberg M.E., Barres B.A., Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74:691-705.
42. Schwarze S.R., Hruska K.A., Dowdy S.F. Protein transduction: unrestricted delivery into all cells?. Trends Cell Biol. 2000, 10:290-295.
43. Sheth P., Samak G., Shull J.A., Seth A., Rao R. Protein phosphatase 2A plays a role in hydrogen peroxide-induced disruption of tight junctions in Caco-2 cell monolayers. Biochem. J. 2009, 421:59-70.
44. Stephan A.H., Barres B.A., Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 2012, 35:369-389.
45. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., et al. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
46. Trevelyan A.J., Sussillo D., Watson B.O., Yuste R. Modular propagation of epileptiform activity: evidence for an inhibitory veto in neocortex. J. Neurosci. 2006, 26:12447-12455.
47. von Lubitz D.K. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?. Eur. J. Pharmacol. 1999, 371:85-102.
48. Wake H., Moorhouse A.J., Jinno S., Kohsaka S., Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 2009, 29:3974-3980.
49. Wake H., Moorhouse A.J., Miyamoto A., Nabekura J. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci. 2013, 36:209-217.
50. Wright S.D., Jong M.T. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp. Med. 1986, 164:1876-1888.
51. Yang M., Kahn A.M. Insulin-stimulated NADH/NAD+ redox state increases NAD(P)H oxidase activity in cultured rat vascular smooth muscle cells. Am. J. Hypertens. 2006, 19:587-592.
52. Zhang W., Dallas S., Zhang D., Guo J.P., Pang H., Wilson B., Miller D.S., Chen B., Zhang W., McGeer P.L., et al. Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein. Glia 2007, 55:1178-1188.
53. Zhang D., Hu X., Qian L., Chen S.H., Zhou H., Wilson B., Miller D.S., Hong J.S. Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity. J. Neuroinflammation 2011, 8:3.
54. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 2011, 12:723-738.